Immunology

D. Kabelitz, A. Bender, S. Schondelmaier, B. Schoel, S.H.E. Kaufmann, "A large fraction of human peripheral blood g/d+ T cells is activated by Mycobacterium tuberculosis but not by its 65-kD heat shock protein," Journal of Experimental Medicine, 171:667-679, 1990. Dieter Kabelitz (University of Heidelberg, Germany): "T cells expressing the g/d+ T cell receptor constitute a distinct class of T cells with as-yet-unknown function. Several groups have recently shown that murine (and some human) g/

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

D. Kabelitz, A. Bender, S. Schondelmaier, B. Schoel, S.H.E. Kaufmann, "A large fraction of human peripheral blood g/d+ T cells is activated by Mycobacterium tuberculosis but not by its 65-kD heat shock protein," Journal of Experimental Medicine, 171:667-679, 1990.

Dieter Kabelitz (University of Heidelberg, Germany): "T cells expressing the g/d+ T cell receptor constitute a distinct class of T cells with as-yet-unknown function. Several groups have recently shown that murine (and some human) g/d+ T cells recognize mycobacterial heat shock proteins (hsp). This has provided a basis for the hypothesis that g/d + 5 T cells might cross-react with autologous hsp, thereby possibly contributing to autoimmune disease.

"In our study, we have compared the frequency of human peripheral blood g/d + T cells that respond to mycobacterial hsp 65 or to heat-killed mycobacteria, respectively. We found that only a minor fraction of g/d + T cells respond to hsp, whereas ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies